Reliv International Inc (RELV) Fair Value & Analysis
Consumer Defensive · US · Market cap $2.6M · ISIN US75952R3084
What is Reliv International Inc really worth?
Reliv International Inc
RELV · US
A solid business, trading 19% below our fair value of $2.26.
Risks
Fair value as of: Aug 13, 2026
From 1 valuation models · updated 19 days ago
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- Solid quality (52/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range ($1.49 to $2.82) leaves room in how you read the outcome.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range $1.75 – $12.60 · fair‑value band $1.49 – $2.82 · the $1.83 price screens below the $2.26 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Reliv International Inc (RELV) currently trades at $1.83, while our model-based Fair Value estimate is $2.26, implying the stock looks roughly 19.0% undervalued today. The Quality Score stands at 52/100 (solid quality), in the Consumer Defensive sector. How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.
Over the trailing twelve months, Reliv International Inc generated revenue of $35.1M at a net margin of −0.5%. Revenue declined 5.3% year over year. It earns a return on equity of −1.5%. The balance sheet holds a net cash position of $1.2M. Fundamentals as of Aug 13, 2026
Our scenario range runs from $1.49 (bear case) to $2.82 (bull case); at $1.83, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 39% below its 52-week high and 8% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −25% fair-value upside, at 24%, RELV screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 1 models by family
Notify me when RELV reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 52 · Market factors (momentum, volatility) 24
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Reliv' International, Inc. develops, manufactures, and markets proprietary nutritional supplements. The company offers joint health, protein, gluten free, targeted solutions, blood sugar support, cellular health, cognitive functions and focus, cholesterol support, kid's nutrition, digestive health, discomfort, energy, aging, heart health, hemp, and immune …
Full company description
Reliv' International, Inc. develops, manufactures, and markets proprietary nutritional supplements. The company offers joint health, protein, gluten free, targeted solutions, blood sugar support, cellular health, cognitive functions and focus, cholesterol support, kid's nutrition, digestive health, discomfort, energy, aging, heart health, hemp, and immune support products. It also provides multivitamins, omega 3s, probiotics, weight management, dairy and soy free, vegetarian, and vegan products. The company offers its products under the fibrestore, Reliv Classic, Innergize!, and LunaRich C brands. It operates in the United States, Canada, Mexico, the United Kingdom, Ireland, Germany, Australia, New Zealand, the Philippines, Malaysia, Singapore, Austria, the Netherlands, and France. The company was founded in 1988 and is headquartered in Chesterfield, Missouri.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Reliv International Inc reported revenue of $20.5M in FY2025 versus $32.6M in FY2021, a compound −10.9%/yr. Reported net income was −$1.6M in FY2025.
Watch RELV: get an alert when its fair value changes →
Peer Group
Packaged Foods · 671 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NESN | CHF 78.62 | CHF 57.26 | −27% |
| Danone S.A BN | €64.28 | €48.41 | −25% |
| Nestlé India Limited NESTLEIND | ₹1,478 | ₹251.94 | −83% |
| The Kraft Heinz Company KHC | $25.13 | $24.59 | −2% |
| Foshan Haitian Flavouring and Food Company 603288 | ¥35.05 | ¥21.93 | −37% |
| Inner Mongolia Yili Industrial Group 600887 | ¥25.51 | ¥32.50 | +27% |
| Yihai Kerry Arawana Holdings 300999 | ¥25.28 | ¥9.89 | −61% |
| General Mills, Inc GIS | $40.44 | $28.32 | −30% |
| Wilmar International Limited F34 | 3.64 SGD | 3.89 SGD | +7% |
| McCormick & Company MKCV | $55.65 | $43.29 | −22% |
Compare Reliv International Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Reliv International Inc (RELV) overvalued or undervalued?
What is the fair value of RELV?
What is the quality score of RELV?
What is the revenue of Reliv International Inc (RELV)?
What is the net profit margin of RELV?
Watch Reliv International Inc in the live analysis
One click puts Reliv International Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.